A Structured Benefit-Risk Assessment Operating Model for Investigational Medicinal Products in the Pharmaceutical Industry
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
A Structured Benefit-Risk Assessment Operating Model for Investigational Medicinal Products in the Pharmaceutical Industry ; volume:57 ; number:4 ; day:1 ; month:4 ; year:2023 ; pages:849-864 ; date:7.2023
Therapeutic innovation & regulatory science ; 57, Heft 4 (1.4.2023), 849-864, 7.2023
- Creator
-
Sullivan, Tim
Zorenyi, Gyorgy
Feron, Jane
Smith, Meredith
Nord, Magnus
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s43441-023-00508-2
- URN
-
urn:nbn:de:101:1-2023092208075455268599
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sullivan, Tim
- Zorenyi, Gyorgy
- Feron, Jane
- Smith, Meredith
- Nord, Magnus
- SpringerLink (Online service)
Other Objects (12)
The Book of Recipes for Pharmaceutical and Medicinal Preparations ... : ABC
Can computer vision problems benefit from structured hierarchical classification?
Basic tests for drugs : pharmaceutical substances, medicinal plant materials and dosage forms
Medicinal Polypharmacology in the Clinic – Translating the Polypharmacolome into Therapeutic Benefit
Cost benefit of investment on quality in pharmaceutical manufacturing: WHO GMP pre- and post-certification of a Nigerian pharmaceutical manufacturer
EC guide to good manufacturing practice for medicinal products and active pharmaceutical ingredients
Innovations in Pharmaceutical Industry : How to Work Towards a Global Benefit for Consumers
Investment certificates under German taxation: Benefit or burden for structured products' performance?
Implementation of a structured emergency nursing framework results in significant cost benefit
High-resolution anoscopy, is there a benefit in proceeding directly to the operating room?
European Coalition on Homoeopathic and Anthroposophic Medicinal Products / Infobroschüre / Review of the Pharmaceutical Legislation.
Medicinal Chemistry Graduate School Curriculum and Its Contribution to the Pharmaceutical Industry in Japan
The Book of Recipes for Pharmaceutical and Medicinal Preparations ... : ABC
Can computer vision problems benefit from structured hierarchical classification?
Basic tests for drugs : pharmaceutical substances, medicinal plant materials and dosage forms
Medicinal Polypharmacology in the Clinic – Translating the Polypharmacolome into Therapeutic Benefit
Cost benefit of investment on quality in pharmaceutical manufacturing: WHO GMP pre- and post-certification of a Nigerian pharmaceutical manufacturer
EC guide to good manufacturing practice for medicinal products and active pharmaceutical ingredients
Innovations in Pharmaceutical Industry : How to Work Towards a Global Benefit for Consumers
Investment certificates under German taxation: Benefit or burden for structured products' performance?
Implementation of a structured emergency nursing framework results in significant cost benefit
High-resolution anoscopy, is there a benefit in proceeding directly to the operating room?
European Coalition on Homoeopathic and Anthroposophic Medicinal Products / Infobroschüre / Review of the Pharmaceutical Legislation.
Medicinal Chemistry Graduate School Curriculum and Its Contribution to the Pharmaceutical Industry in Japan
The Book of Recipes for Pharmaceutical and Medicinal Preparations ... : ABC
Can computer vision problems benefit from structured hierarchical classification?
Basic tests for drugs : pharmaceutical substances, medicinal plant materials and dosage forms
Medicinal Polypharmacology in the Clinic – Translating the Polypharmacolome into Therapeutic Benefit
Cost benefit of investment on quality in pharmaceutical manufacturing: WHO GMP pre- and post-certification of a Nigerian pharmaceutical manufacturer
EC guide to good manufacturing practice for medicinal products and active pharmaceutical ingredients
Innovations in Pharmaceutical Industry : How to Work Towards a Global Benefit for Consumers
Investment certificates under German taxation: Benefit or burden for structured products' performance?
Implementation of a structured emergency nursing framework results in significant cost benefit
High-resolution anoscopy, is there a benefit in proceeding directly to the operating room?
European Coalition on Homoeopathic and Anthroposophic Medicinal Products / Infobroschüre / Review of the Pharmaceutical Legislation.